GlassScriptPhysician profile
David Richard Steinberg
NPI 1285662783
$5,134.03
in general payments reported to CMS, 2019-2025
15 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what 75% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $732 · 2021: $525 · 2022: $792 · 2023: $78.34 · 2024: $802 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $490.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $4,012.00 | 2019-2025 | |
| Axogen | $272.84 | 2019-2025 | |
| Integra Lifesciences Corporation | $162.10 | 2022 | |
| Acumed LLC | $138.48 | 2020 | |
| Depuy Synthes Sales INC. | $119.67 | 2025 | Va-Lcp |
| Medartis INC. | $115.97 | 2019-2022 | |
| Checkpoint Surgical, INC | $68.43 | 2020 | |
| Bioventus LLC | $41.66 | 2023 | Durolane |
| Endo Pharmaceuticals INC. | $41.45 | 2019-2024 | Xiaflex |
| Anika Therapeutics, INC. | $38.34 | 2024 | Ovo Motion, Revomotion |
| Paladin Technology Solutions | $36.68 | 2023 | |
| Polynovo North America LLC | $31.36 | 2025 | Novosorb Btm |
| Dynasplint Systems INC. | $30.56 | 2019 | |
| Smith+Nephew, INC. | $24.49 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.